Colgate-Palmolive Stock - Analyst consensus and technical view on a quiet Thursday
18.06.2026 - 18:15:33 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 18:13 CET. Details in the imprint.
Colgate-Palmolive (US1941621039) is trading today with no new company-specific headlines from major wires or its investor-relations site, according to a review of market news feeds. With the news flow muted, attention turns to analyst consensus and the stock’s technical backdrop.
All news and data on Colgate-Palmolive stock
Find additional market coverage, price data and regulatory disclosures on Colgate-Palmolive in the ad hoc news topic hub and on the company’s own investor-relations pages.
What analysts are signaling
For Colgate-Palmolive stock, data compiled by Investing.com show a “Buy” consensus rating based on input from around 20 analysts covering the consumer products group. According to the same overview, 13 analysts rate the stock a buy, 8 suggest holding, and none recommend selling.
The average 12-month price target in that sample stands at $95.85, with estimates ranging from a low of $80 to a high of $105 per share. Against a recently indicated spot quote near $90.58, the consensus implies modest upside from current levels.
Valuation snapshot and peer context
Colgate-Palmolive sits in the defensive consumer staples corner of the Standard & Poor’s 500 index, alongside names like Procter & Gamble and Kimberly-Clark. Investors often view such stocks as relatively resilient in slower macro environments because demand for oral care and household products tends to be steady.
On many fundamental screens Colgate-Palmolive trades at a premium to the broader market, reflecting its strong brand portfolio and historically robust margins. Net-net, the current analyst mix suggests cautious optimism rather than a contrarian stance on the stock.
Technical picture on the chart
On the technical side, indicative data from third-party quote services place Colgate-Palmolive stock around $90.58 as of 06/18/2026, translating to roughly EUR 78.80 on European platforms at recent exchange rates. The European quote on Finanzen100 shows the stock in that euro range during the latest session.
At this level, the stock trades below some published 12-month price targets but not far from its own recent highs, suggesting a balanced risk-reward profile from a chart perspective rather than an obviously stretched or deeply depressed setup. Volatility also appears muted compared with high-growth technology names.
How Colgate-Palmolive makes its money
Colgate-Palmolive generates most of its revenue from branded consumer products in oral care, personal care, home care and pet nutrition, with its flagship Colgate toothpaste line a core pillar of the business. The company sells these products globally through supermarkets, pharmacies and other retail channels.
Where the stock trades today
The shares of Colgate-Palmolive (US1941621039) trade on the New York Stock Exchange under the ticker CL at about $90.58 as of 06/18/2026, 16:00 UTC.
Key facts on Colgate-Palmolive stock
- Company: Colgate-Palmolive Company
- ISIN: US1941621039
- WKN: 850667
- Ticker: CL
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 UTC): 90.58 USD
- Market cap: 74,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Consumer Staples / Household & Personal Products
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
